Form D · Biotechnology
Incline Therapeutics, Inc.
Redwood City, CA · CIK 0001481336
Offering snapshot reported Sep 27, 2011 · SEC filing
- Reported sold
- $21.5M Offering amount: $21.5M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Sep 13, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 27, 2011 | Initial | $21,500,000 | No comparison | 15 | SEC filing |
| Jun 30, 2010 | Initial | $22,000,000 | No comparison | 17 | SEC filing |
| Jan 20, 2010 | Initial | $440,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-166453
Source: Form D, filed Sep 27, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jim Glasheen | Director |
| James Glasheen, Ph.D. | Director |
| Terry Gould | Director |
| Alan Levy, Ph.D. | Director, Executive |
| Theodore R. Schroeder | Director |
| David A. Socks | Executive |
| James Topper | Director |
| James Topper, M.D., Ph.D. | Director |
| Jim Young | Director |
| James W. Young, Ph.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
900 Saginaw Drive, Suite 200
Redwood City, CA, 94063
Redwood City, CA, 94063